DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.
Cendrowicz E, Jacob L, Greenwald S, Tamir A, Pecker I, Tabakman R, Ghantous L, Tamir L, Kahn R, Avichzer J, Aronin A, Amsili S, Zorde-Khvalevsky E, Gozlan Y, Vlaming M, Huls G, van Meerten T, Dranitzki ME, Foley-Comer A, Pereg Y, Peled A, Chajut A, Bremer E.
Cendrowicz E, et al. Among authors: aronin a.
J Exp Clin Cancer Res. 2022 Mar 14;41(1):97. doi: 10.1186/s13046-022-02256-x.
J Exp Clin Cancer Res. 2022.
PMID: 35287686
Free PMC article.